✦ LIBER ✦

ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis

✍ Scribed by Henrik S. Thomsen

Book ID: 113031555
Publisher: Springer
Year: 2007
Tongue: English
Weight: 77 KB
Volume: 17
Category: Article
ISSN: 0938-7994
DOI: 10.1007/s00330-007-0744-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nephrogenic systemic fibrosis and gadoli

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

✍ Thomsen, Henrik S.; Morcos, Sameh K.; Almén, Torsten; Bellin, Marie-France; Bert 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 238 KB

Nephrogenic systemic fibrosis and the ro

Nephrogenic systemic fibrosis and the role of gadolinium contrast media

✍ AJ Van Der Molen 📂 Article 📅 2008 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 126 KB

Nephrogenic systemic fibrosis: UK survey

Nephrogenic systemic fibrosis: UK survey of the use of gadolinium-based contrast media

✍ O. Rees; S.K. Agarwal 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 365 KB

Nephrogenic systemic fibrosis and the us

Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents

✍ Jeffrey G. Penfield 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 167 KB

Nephrogenic Systemic Fibrosis and Gadoli

Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast: What’s a Nephrologist to Do?

✍ Mark A. Perazella 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Biochemical safety profiles of gadoliniu

Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis

✍ Hale Ersoy; Frank J. Rybicki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Gadolinium (Gd)‐based paramagnetic contrast agents are relatively safe when used in clinically recommended doses. However, with the rapidly expanding body of literature linking Gd‐based paramagnetic contrast agents and nephrogenic systemic fibrosis (NSF), awareness of the potential side